{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:16:36Z","timestamp":1791353796051,"version":"4.3.1"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Although multiple hormones and cytokines regulate various aspects of osteoclast formation, the final two effectors are osteoprotegerin ligand (OPG-L)\/osteoclast differentiation factor (ODF), a recently cloned member of the tumor necrosis factor superfamily, and macrophage colony\u2013stimulating factor. OPG-L\/ODF is produced by osteoblast lineage cells and exerts its biological effects through binding to its receptor, osteoclast differentiation and activation receptor (ODAR)\/receptor activator of NF-\u03baB (RANK), on osteoclast lineage cells, in either a soluble or a membrane-bound form, the latter of which requires cell-to-cell contact. Binding results in rapid differentiation of osteoclast precursors in bone marrow to mature osteoclasts and, at higher concentrations, in increased functional activity and reduced apoptosis of mature osteoclasts. The biological activity of OPG-L\/ODF is neutralized by binding to osteoprotegerin (OPG)\/osteoclastogenesis inhibitory factor (OCIF), a member of the TNF-receptor superfamily that also is secreted by osteoblast lineage cells. The biological importance of this system is underscored by the induction in mice of severe osteoporosis by targeted ablation of OPG\/OCIF and by the induction of osteopetrosis by targeted ablation of OPG-L\/ODF or overexpression of OPG\/OCIF. Thus, osteoclast formation may be determined principally by the relative ratio of OPG-L\/ODF to OPG\/OCIF in the bone marrow microenvironment, and alterations in this ratio may be a major cause of bone loss in many metabolic disorders, including estrogen deficiency and glucocorticoid excess. That changes in but two downstream cytokines mediate the effects of large numbers of upstream hormones and cytokines suggests a regulatory mechanism for osteoclastogenesis of great efficiency and elegance.<\/jats:p>","DOI":"10.1359\/jbmr.2000.15.1.2","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T01:45:01Z","timestamp":1146102301000},"page":"2-12","source":"Crossref","is-referenced-by-count":931,"title":["The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption"],"prefix":"10.1093","volume":"15","author":[{"given":"Lorenz C.","family":"Hofbauer","sequence":"first","affiliation":[{"name":"Endocrine Research Unit, Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Dunstan","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Lacey","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Boyle","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Lawrence","family":"Riggs","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020714111593300_bib1","first-page":"66","article-title":"Modulation of osteoclast differentiation","volume":"13","author":"Suda","year":"1992","journal-title":"Endocr Rev"},{"key":"2024020714111593300_bib2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1359\/jbmr.1997.12.6.869","article-title":"Regulation of osteoclast function","volume":"12","author":"Suda","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib3","first-page":"308","article-title":"Advances in bone biology: The osteoclast","volume":"17","author":"Roodman","year":"1996","journal-title":"Endocr Rev"},{"key":"2024020714111593300_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukarGeneExpr.v8.i1.10","article-title":"Control of osteoclast differentiation","volume":"8","author":"Reddy","year":"1998","journal-title":"Crit Rev Eukaryot Gene Exp"},{"key":"2024020714111593300_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","article-title":"Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis","volume":"11","author":"Pacifici","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis","volume":"332","author":"Manolagas","year":"1995","journal-title":"N Engl J Med"},{"key":"2024020714111593300_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S8756-3282(98)00077-5","article-title":"Cytokines, bone remodeling, and estrogen deficiency: A 1998 update","volume":"23","author":"Jilka","year":"1998","journal-title":"Bone"},{"key":"2024020714111593300_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"2024020714111593300_bib9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"39","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"2024020714111593300_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"2024020714111593300_bib11","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotege- rin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"2024020714111593300_bib12","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"issue":"Suppl 1","key":"2024020714111593300_bib14","first-page":"S149","article-title":"Identification of an OSF-2 binding sitein the murine RANKL\/OPGL gene promoter: A potential link between osteoblastogenesis and osteoclastogenesis (abstract 1003)","volume":"23","author":"O'Brien","year":"1998","journal-title":"Bone"},{"key":"2024020714111593300_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/bbrc.1998.9643","article-title":"Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: Regulation of mRNA expression of osteoclast differentiation factor (ODF)","volume":"252","author":"Gao","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib16","doi-asserted-by":"crossref","first-page":"in press","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"2024020714111593300_bib17","first-page":"in press","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1, but not interleukin-6 stimulate osteoprotegerin ligand gene expression in human osteoblastic cells","volume":"24","author":"Hofbauer","year":"1999","journal-title":"Bone"},{"key":"2024020714111593300_bib18","doi-asserted-by":"crossref","first-page":"27091","DOI":"10.1074\/jbc.273.42.27091","article-title":"Transforming growth factor-\u03b2 stimulates the production of osteoprotegerin\/osteoclastogenesis inhibitory factor by bone marrow stromal cells","volume":"273","author":"Takai","year":"1998","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib19","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1210\/endo.139.10.6331","article-title":"A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro","volume":"139","author":"Quinn","year":"1998","journal-title":"Endocrinology"},{"key":"2024020714111593300_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/bbrc.1998.8586","article-title":"Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures","volume":"246","author":"Matsuzaki","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1084\/jem.188.5.997","article-title":"TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts","volume":"188","author":"Fuller","year":"1998","journal-title":"J Exp Med"},{"key":"2024020714111593300_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","article-title":"The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts","volume":"145","author":"Burgess","year":"1999","journal-title":"J Cell Biol"},{"key":"2024020714111593300_bib23","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.274.19.13613","article-title":"Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival","volume":"274","author":"Lum","year":"1999","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib24","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1074\/jbc.273.7.4119","article-title":"The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells","volume":"273","author":"Yao","year":"1998","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endo.140.1.6451","article-title":"Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones","volume":"140","author":"Lea","year":"1999","journal-title":"Endocrinology"},{"key":"2024020714111593300_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.1998.8610","article-title":"Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1\u03b1,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone","volume":"246","author":"Tsukii","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib27","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/endo.139.9.6290","article-title":"Hypocalcemic effect of osteoclastogenesis inhibitory factor\/osteoprotegerin in the thyroparathyroidectomized rat","volume":"139","author":"Yamamoto","year":"1998","journal-title":"Endocrinology"},{"key":"2024020714111593300_bib28","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.186.12.2075","article-title":"TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor","volume":"186","author":"Wong","year":"1997","journal-title":"J Exp Med"},{"key":"2024020714111593300_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"2024020714111593300_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/bbrc.1999.0163","article-title":"Excessive extramedullary hematopoiesis in cbfa1-deficient mice with a congenital lack of bone marrow","volume":"255","author":"Deguchi","year":"1999","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib31","doi-asserted-by":"crossref","first-page":"20551","DOI":"10.1074\/jbc.273.32.20551","article-title":"Characterization of the intracellular domain of receptor activator of NF-\u03baB (RANK)","volume":"273","author":"Darnay","year":"1998","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib32","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"2024020714111593300_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","article-title":"RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis","volume":"253","author":"Nakagawa","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib34","doi-asserted-by":"crossref","first-page":"28355","DOI":"10.1074\/jbc.273.43.28355","article-title":"The TRAF family of signal transducers mediates NF-\u03baB activation by the TRANCE receptor","volume":"273","author":"Wong","year":"1998","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib35","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-\u03baB1 and NF-\u03baB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nature Med"},{"key":"2024020714111593300_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/360741a0","article-title":"Bone and hematopoietic defects in mice lacking c-fos","volume":"360","author":"Wang","year":"1992","journal-title":"Nature"},{"key":"2024020714111593300_bib37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(92)90592-Z","article-title":"Pleiotropic effects of a null mutation in the c-fos proto-oncogene","volume":"71","author":"Johnson","year":"1992","journal-title":"Cell"},{"key":"2024020714111593300_bib38","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1101\/gad.12.18.2821","article-title":"Tumor necrosis factor receptor-associated factors (TRAFs)\u2014A family of adapter proteins that regulates life and death","volume":"12","author":"Arch","year":"1998","journal-title":"Genes Dev"},{"key":"2024020714111593300_bib39","doi-asserted-by":"crossref","first-page":"34120","DOI":"10.1074\/jbc.273.51.34120","article-title":"The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanism of receptor activator of NF-\u03baB, a member of the TNFR superfamily","volume":"273","author":"Galibert","year":"1998","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib40","doi-asserted-by":"crossref","first-page":"24775","DOI":"10.1074\/jbc.273.38.24775","article-title":"An intact zinc finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-\u03baB activation but is dispensible for c-Jun N-terminal kinase signaling","volume":"273","author":"Dadgostar","year":"1998","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib41","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6-deficiency results in osteopetrosis and defective interleukin-1, CD40 and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev"},{"key":"2024020714111593300_bib42","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1074\/jbc.274.12.7724","article-title":"Activation of NF-\u03baB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-\u03baB-inducing kinase. Identification of a novel TRAF6 interaction motif","volume":"274","author":"Darnay","year":"1999","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"Tsuda","year":"1997","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-1119(97)00509-X","article-title":"Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells","volume":"204","author":"Tan","year":"1997","journal-title":"Gene"},{"key":"2024020714111593300_bib45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1096\/fasebj.12.10.845","article-title":"TR1, a new member of the tumor necrosis factor receptor family, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption","volume":"12","author":"Kwon","year":"1998","journal-title":"FASEB J"},{"key":"2024020714111593300_bib46","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.161.11.6113","article-title":"OPG\/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40","volume":"161","author":"Yun","year":"1998","journal-title":"J Immunol"},{"key":"2024020714111593300_bib47","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1074\/jbc.273.9.5117","article-title":"Characterization of structural domains of human osteoclastogenesis inhibitory factor","volume":"273","author":"Yamaguchi","year":"1998","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/bbrc.1998.8443","article-title":"Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor","volume":"245","author":"Tomoyasu","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/bbrc.1998.9294","article-title":"Osteoclastogenesis-inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast","volume":"250","author":"Akatsu","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/joe.0.1590191","article-title":"Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids","volume":"159","author":"Vidal","year":"1998","journal-title":"J Endocrinol"},{"key":"2024020714111593300_bib51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1006\/bbrc.1998.9394","article-title":"Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines","volume":"250","author":"Hofbauer","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib52","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"2024020714111593300_bib53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1006\/bbrc.1998.9035","article-title":"Osteoprotegerin mRNA is increased by interleukin-\u03b1 in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells","volume":"248","author":"Vidal","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/bbrc.1998.8993","article-title":"Tumor necrosis factor-\u03b1 and -\u03b2 upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells","volume":"248","author":"Br\u00e4ndstr\u00f6m","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib55","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1006\/bbrc.1998.9723","article-title":"Transforming growth factor-\u03b21 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic\/stromal cells and inhibits the survival of murine osteoclast-like cells","volume":"252","author":"Murakami","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib56","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/bbrc.1998.8783","article-title":"Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells","volume":"247","author":"Br\u00e4ndstr\u00f6m","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0378-1119(98)00295-9","article-title":"Structure of the mouse osteoclastogenesis inhibitory factor\/osteoprotegerin gene and its expression in embryogenesis","volume":"215","author":"Mizuno","year":"1998","journal-title":"Gene"},{"key":"2024020714111593300_bib58","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1006\/bbrc.1997.8046","article-title":"Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts","volume":"242","author":"Miyamoto","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib59","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"2024020714111593300_bib60","first-page":"S155","article-title":"Recombinant osteoprotegerin (OPG), a novel TNF-receptor family member, inhibits in vitro murine osteoclast formation from bone marrow precursors (abstract P213)","volume":"12","author":"Tan","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib61","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1006\/bbrc.1998.9523","article-title":"Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts","volume":"251","author":"Hakeda","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib62","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"2024020714111593300_bib63","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem Biophys Res Com"},{"key":"2024020714111593300_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002239900419","article-title":"Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women","volume":"62","author":"Barengolts","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"2024020714111593300_bib65","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1073\/pnas.85.15.5683","article-title":"Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures","volume":"85","author":"Chenu","year":"1988","journal-title":"Proc Natl Acad Sci"},{"key":"2024020714111593300_bib66","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1172\/JCI113647","article-title":"Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures","volume":"82","author":"Pfeilschifter","year":"1988","journal-title":"J Clin Invest"},{"key":"2024020714111593300_bib67","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"issue":"Suppl 1","key":"2024020714111593300_bib68","first-page":"S190","article-title":"Mechanisms by which NF-\u03baB regulates osteoclast numbers (abstract 1172)","volume":"23","author":"Hing","year":"1998","journal-title":"Bone"},{"key":"2024020714111593300_bib69","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","article-title":"STAT3 activation in stromal\/osteoblastic cells is required for induction of the receptor activator of NF-\u03baB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1.25-dihydroxyvitamin D3 or parathyroid hormone","volume":"274","author":"O'Brien","year":"1999","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib70","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1083\/jcb.142.5.1347","article-title":"Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption","volume":"142","author":"Adebanjo","year":"1998","journal-title":"J Cell Biol"},{"key":"2024020714111593300_bib71","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib72","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/mend.13.6.0299","article-title":"The actions and interactions of sex steroids and growth factors\/cytokines on the skeleton","volume":"13","author":"Spelsberg","year":"1999","journal-title":"Mol Enocrinol"},{"key":"2024020714111593300_bib73","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jbmr.5650110203","article-title":"A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates","volume":"11","author":"Parfitt","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib74","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1172\/JCI117606","article-title":"Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice","volume":"94","author":"Kitazawa","year":"1994","journal-title":"J Clin Invest"},{"key":"2024020714111593300_bib75","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.1997.12.6.935","article-title":"The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice","volume":"12","author":"Kimble","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"2024020714111593300_bib77","doi-asserted-by":"crossref","first-page":"28890","DOI":"10.1074\/jbc.271.46.28890","article-title":"Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor","volume":"271","author":"Kimble","year":"1996","journal-title":"J Biol Chem"},{"key":"2024020714111593300_bib78","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI118066","article-title":"Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae","volume":"96","author":"Kawaguchi","year":"1995","journal-title":"J Clin Invest"},{"key":"2024020714111593300_bib79","first-page":"1135","article-title":"Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen\/progesterone therapy","volume":"77","author":"Pacifici","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714111593300_bib80","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1073\/pnas.91.12.5227","article-title":"Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells","volume":"91","author":"Oursler","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"2024020714111593300_bib81","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta","volume":"2","author":"Hughes","year":"1997","journal-title":"Nature Med"},{"key":"2024020714111593300_bib82","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/endo-129-6-3313","article-title":"Modulation of transforming growth factor-\u03b2 production in normal human osteoblast-like cells by 17\u03b2-estradiol and parathyroid hormone","volume":"129","author":"Oursler","year":"1991","journal-title":"Endocrinology"},{"key":"2024020714111593300_bib83","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/endo.137.2.8593810","article-title":"Osteoclasts and transforming growth factor-\u03b2: Estrogen-mediated isoform-specific regulation of production","volume":"137","author":"Robinson","year":"1996","journal-title":"Endocrinology"},{"key":"2024020714111593300_bib84","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"2024020714111593300_bib85","first-page":"S298","article-title":"Osteoprotegerin serum levels in healthy volunteers (abstract T411)","volume":"23","author":"Arrighi","year":"1998","journal-title":"Bone"},{"key":"2024020714111593300_bib86","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-112-5-352","article-title":"Glucocorticoid-induced osteoporosis: pathogenesis and management","volume":"112","author":"Lukert","year":"1990","journal-title":"Ann Intern Med"},{"key":"2024020714111593300_bib87","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/eje.0.1370209","article-title":"Glucocorticoid osteoporosis\u2014Mechanisms and management","volume":"137","author":"Reid","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2024020714111593300_bib88","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jbmr.5650111008","article-title":"Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone","volume":"11","author":"Conaway","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib89","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1359\/jbmr.1997.12.5.734","article-title":"Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2","volume":"12","author":"Kaji","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib90","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jbmr.5650051206","article-title":"Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro","volume":"5","author":"Gronowicz","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib91","first-page":"1863","article-title":"Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome","volume":"83","author":"Chiodini","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714111593300_bib92","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0026-0495(66)90169-7","article-title":"Quantitative microradiographic study of bone remodeling in Cushing's syndrome","volume":"15","author":"Riggs","year":"1966","journal-title":"Metabolism"},{"key":"2024020714111593300_bib93","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650040202","article-title":"Bone histomorphometry in glucocorticoid-induced osteoporosis","volume":"4","author":"Dempster","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"2024020714111593300_bib94","first-page":"S486","article-title":"Serum levels of osteoprotegerin: Effects of glucocorticoids and growth hormone (abstract F321)","volume":"23","author":"Bornefalk","year":"1998","journal-title":"Bone"},{"issue":"Suppl 1","key":"2024020714111593300_bib95","first-page":"S136","article-title":"Osteoprotegerin (OPG), a novel TNF-receptor family member, profoundly inhibits endosteal bone resorption due to growth, humoral hypercalcemia of malignancy, and interleukin 1 (abstract 134)","volume":"12","author":"Dunstan","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020714111593300_bib96","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S8756-3282(98)00141-0","article-title":"Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy","volume":"23","author":"Akatsu","year":"1998","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2000.15.1.2","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/15\/1\/2\/56603609\/5650150102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/15\/1\/2\/56603609\/5650150102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:59:06Z","timestamp":1710341946000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/15\/1\/2-12\/7515518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1,1]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2000,1,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2000.15.1.2","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,1,1]]},"published":{"date-parts":[[2000,1,1]]}}}